Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Ltd
Press Release May 03 2022
Business
May 3 2022
3 min read

Press Release May 03 2022

Aurobindo Pharma Limited has informed the Exchange about press release dated 03-May-2022 titled Press Release on USFDA approval for Bortezomib for Injection received by Eugia Pharma

View Attachment